CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer
CEACAM6作为一种基于机器学习的免疫生物标志物，可用于预测HR+/HER2-乳腺癌新辅助化疗的疗效
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1662004
Fang, Dalang; Lin, Jie; Wang, Jin; Nong, Qingxiao; Tao, Shouwen; Lu, Bimin; Yu, Yanrong; Peng, Hao; Tian, Yingying; Su, Qunying; Ma, Yanfei; Huang, Yuanlu
肿瘤
HER2
肿瘤免疫
乳腺癌
CEACAM6
免疫/内分泌
